From Casetext: Smarter Legal Research

Teater v. Pfizer, Inc.

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF OREGON PORTLAND DIVISION
Jun 6, 2013
Case No. 3:05-cv-00604-HU (D. Or. Jun. 6, 2013)

Summary

In Teater v. Pfizer, Inc., 3:05-CV-00604-HU, 2013 WL 2455995 (D. Or. June 6, 2013), the plaintiff brought a products liability claim against a pharmaceutical company alleging that “‘Neurontin caused [her] to attempt to commit suicide.'” Id. at *6.

Summary of this case from Derby v. Columbia Cnty.

Opinion

Case No. 3:05-cv-00604-HU

06-06-2013

TERESA E.A. TEATER, Plaintiff, v. PFIZER, INC., et al., Defendants.


ORDER ADOPTING FINDINGS AND

RECOMMENDATION

Michael H. Simon, District Judge.

United States Magistrate Judge Dennis J. Hubel issued Findings and Recommendation in this case on May 13, 2013. Dkt. 112. Judge Hubel recommended that Plaintiff's Motion to Enlarge Time to File Expert Designations (Dkt. 99) be granted and Defendants' Motion for Summary Judgment (Dkt. 84) be granted. No party has filed objections.

Under the Federal Magistrates Act ("Act"), the court may "accept, reject or modify, in whole or in part, the findings or recommendations made by the magistrate." 28 U.S.C. § 636(b)(1). If a party files objections to a magistrate's findings and recommendations, "the court shall make a de novo determination of those portions of the report or specified proposed findings or recommendations to which objection is made." Id.; Fed. R. Civ. P. 72(b)(3).

If no party objects, the Act does not prescribe any standard of review. See Thomas v. Arn, 474 U.S. 140, 152 (1985) ("There is no indication that Congress, in enacting [the Act], intended to require a district judge to review a magistrate's report[.]"); United States. v. Reyna-Tapia, 328 F.3d 1114, 1121 (9th Cir. 2003) (en banc)(the court must review de novo magistrate's findings and recommendations if objection is made, "but not otherwise").

Although review is not required in the absence of objections, the Act "does not preclude further review by the district judge[] sua sponte . . . under a de novo or any other standard." Thomas, 474 U.S. at 154. Indeed, the Advisory Committee Notes to Fed. R. Civ. P. 72(b) recommend that "[w]hen no timely objection is filed," the court review the magistrate's findings and recommendations for "clear error on the face of the record."

No party having made objections, this Court follows the recommendation of the Advisory Committee and reviews Judge Hubel's Findings and Recommendation for clear error on the face of the record. No such error is apparent. Accordingly, the Court ADOPTS Judge Hubel's Findings and Recommendation, Dkt. 112. Plaintiff's Motion to Enlarge Time to File Expert Designations (Dkt. 99) is GRANTED. Defendants' Motion for Summary Judgment (Dkt. 84) is GRANTED. This case is DISMISSED.

IT IS SO ORDERED.

________________________

Michael H. Simon

United States District Judge


Summaries of

Teater v. Pfizer, Inc.

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF OREGON PORTLAND DIVISION
Jun 6, 2013
Case No. 3:05-cv-00604-HU (D. Or. Jun. 6, 2013)

In Teater v. Pfizer, Inc., 3:05-CV-00604-HU, 2013 WL 2455995 (D. Or. June 6, 2013), the plaintiff brought a products liability claim against a pharmaceutical company alleging that “‘Neurontin caused [her] to attempt to commit suicide.'” Id. at *6.

Summary of this case from Derby v. Columbia Cnty.
Case details for

Teater v. Pfizer, Inc.

Case Details

Full title:TERESA E.A. TEATER, Plaintiff, v. PFIZER, INC., et al., Defendants.

Court:UNITED STATES DISTRICT COURT FOR THE DISTRICT OF OREGON PORTLAND DIVISION

Date published: Jun 6, 2013

Citations

Case No. 3:05-cv-00604-HU (D. Or. Jun. 6, 2013)

Citing Cases

Mindiola v. State

Accordingly, the Court concludes that the third and fourth factors weigh in favor of accepting the filing.…

Hobus v. Howmedica Osteonics Corp.

Therefore, summary judgment on his claims is appropriate. See Teater v. Pfizer, Inc., No.…